These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 1907793

  • 1. [The protective activity of 2 normal immunoglobulin preparations for intravenous administration in experimental Pseudomonas aeruginosa infection].
    Vasilev ChL, Veleva KV, Tekelieva RKh, Pencheva PI.
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Feb; (2):54-6. PubMed ID: 1907793
    [Abstract] [Full Text] [Related]

  • 2. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS, Roby RE.
    Am J Med; 1984 Mar 30; 76(3A):168-74. PubMed ID: 6424446
    [Abstract] [Full Text] [Related]

  • 3. [Protective action of various antibody preparations in experimental bacterial sepsis].
    Trautmann M, Brückner O, Hofstaetter T, Seiler FR, Hahn H.
    Beitr Infusionther Klin Ernahr; 1982 Mar 30; 9():155-65. PubMed ID: 6816213
    [No Abstract] [Full Text] [Related]

  • 4. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ, Gerçeker AA, Koles NL, Pollack M, Pier GB.
    Invest Ophthalmol Vis Sci; 1997 Jun 30; 38(7):1418-25. PubMed ID: 9191605
    [Abstract] [Full Text] [Related]

  • 5. [Comparative study of the antibody concentration and protective activity against Pseudomonas aeruginosa of gamma-globulin and IgM-enriched immunoglobulin preparations].
    Kiseleva IA, Kandiurina VG, Timofeeva GV.
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr 30; (4):68-71. PubMed ID: 2424197
    [Abstract] [Full Text] [Related]

  • 6. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE, Pier GB, Sadoff JC, Small GJ.
    Rev Infect Dis; 1986 Apr 30; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [Abstract] [Full Text] [Related]

  • 7. Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.
    Hemachandra S, Kamboj K, Copfer J, Pier G, Green LL, Schreiber JR.
    Infect Immun; 2001 Apr 30; 69(4):2223-9. PubMed ID: 11254577
    [Abstract] [Full Text] [Related]

  • 8. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
    Kinoshita M, Kato H, Yasumoto H, Shimizu M, Hamaoka S, Naito Y, Akiyama K, Moriyama K, Sawa T.
    Hum Vaccin Immunother; 2016 Nov 30; 12(11):2833-2846. PubMed ID: 27454613
    [Abstract] [Full Text] [Related]

  • 9. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN, Holder IA.
    Antibiot Chemother (1971); 1987 Nov 30; 39():26-40. PubMed ID: 3118788
    [No Abstract] [Full Text] [Related]

  • 10. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z, Kimmel R, Petersen S, Thomas S, Pier G, Bezabeh B, Luo R, Schreiber JR.
    Vaccine; 2005 May 09; 23(25):3264-71. PubMed ID: 15837231
    [Abstract] [Full Text] [Related]

  • 11. Protection against infection with Pseudomonas aeruginosa by passive transfer of monoclonal antibodies to lipopolysaccharides and outer membrane proteins.
    Sawada S, Suzuki M, Kawamura T, Fujinaga S, Masuho Y, Tomibe K.
    J Infect Dis; 1984 Oct 09; 150(4):570-6. PubMed ID: 6436393
    [Abstract] [Full Text] [Related]

  • 12. [Natural antibodies against Pseudomonas aeruginosa in human gamma globulin preparations].
    Chekan LV, Min'ovich FL, Kutimova LR, Edvabnaia LS, Stanislavskiĭ ES.
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun 09; (6):85-9. PubMed ID: 6170196
    [Abstract] [Full Text] [Related]

  • 13. Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice.
    Collins MS, Roby RE.
    J Trauma; 1983 Jun 09; 23(6):530-4. PubMed ID: 6408266
    [Abstract] [Full Text] [Related]

  • 14. [Antibodies against Pseudomonas aeruginosa toxin in preparations of normal human immunoglobulin].
    Ianishevskaia MN, Kuz'mina NS, Kutimova LR, Lents MN, Minakova LV.
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun 09; (6):100-3. PubMed ID: 6412489
    [Abstract] [Full Text] [Related]

  • 15. Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo.
    Collins MS, Dorsey JH.
    Am J Med; 1984 Mar 30; 76(3A):155-60. PubMed ID: 6424444
    [Abstract] [Full Text] [Related]

  • 16. Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in humans.
    Pollack M.
    J Infect Dis; 1983 Jun 30; 147(6):1090-8. PubMed ID: 6406615
    [Abstract] [Full Text] [Related]

  • 17. Clinical evaluation of Pseudomonas hyperimmune globulin and plasma.
    Jones CE, Alexander JW, Fisher MW.
    Surg Forum; 1970 Jun 30; 21():238-40. PubMed ID: 4105882
    [No Abstract] [Full Text] [Related]

  • 18. The first clinical trial of immuno's experimental Pseudomonas aeruginosa flagellar vaccines.
    Crowe BA, Enzersberger O, Schober-Bendixen S, Mitterer A, Mundt W, Livey I, Pabst H, Kaeser R, Eibl M, Eibl J.
    Antibiot Chemother (1971); 1991 Jun 30; 44():143-56. PubMed ID: 1801633
    [No Abstract] [Full Text] [Related]

  • 19. Human monoclonal antibodies that protect mice against challenge with Pseudomonas aeruginosa.
    Zweerink HJ, Gammon MC, Hutchison CF, Jackson JJ, Lombardo D, Miner KM, Puckett JM, Sewell TJ, Sigal NH.
    Infect Immun; 1988 Aug 30; 56(8):1873-9. PubMed ID: 3135264
    [Abstract] [Full Text] [Related]

  • 20. Human IgG antibodies to Pseudomonas aeruginosa core lipopolysaccharide determinants are detected in chronic but not acute pseudomonas infection.
    Jacobson MA, Radolf JD, Young LS.
    Scand J Infect Dis; 1987 Aug 30; 19(6):649-60. PubMed ID: 3126549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.